University of British Columbia
Causal effect of stroke on subsequent oral anticoagulant adherence in patients with atrial fibrillation (Causal-AF)
Abstract
dc:descriptionObjective: Atrial fibrillation (AF) increases ischemic stroke (IS) risk, and while oral anticoagulant (OAC) therapy is essential for prevention, adherence after IS remains a challenge. Poor adherence in this group could contribute to recurrent IS, higher mortality, and increased healthcare costs. This study aimed to investigate the causal effect of IS on OAC adherence among AF patients. Methods: A scoping review was conducted to assess the existing evidence on the association and causation between IS and OAC adherence among AF patients. A retrospective cohort study using administrative health data from British Columbia was then conducted. Adherence was measured using the proportion of days covered (PDC), and patients with PDC >80% were classified as adherent. A Directed Acyclic Graph (DAG) was developed to identify confounders, mediators, and effect modifiers. The causal effect of IS on OAC adherence was estimated using inverse probability of treatment weighting (IPTW) and covariate-adjusted regression models. Results: The scoping review of 42 studies showed positive (n=26), negative (n=1), and no association (n=15) between IS and OAC adherence. Application of Bradford Hill’s criteria provided a structured approach to evaluating the plausibility of a causal relationship in these observational studies. Our adjusted regression models showed that the mean PDC was higher for the IS group (0.74) compared to the non-IS group (0.70). IS was associated with 23% higher odds of being adherent. The DAG identified key confounders, including age, sex, socioeconomic status, prior stroke/TIA, hypertension, antiplatelet use, diabetes, heart failure, and vascular disease. Mediators were stroke severity, recurrent IS, type of OAC initiated, and OAC class switch. The causal effect analyses demonstrated that IS had a positive causal effect on OAC adherence. Conclusion: We showed that IS has a positive causal effect on OAC adherence, driven by factors such as OAC class switch, type of OAC initiated, IS severity, and recurrence. The observed adherence increase is projected to reduce recurrent IS risk by 4.1%. Clinicians should not only focus on preventing recurrent IS but also proactively engage high-risk patients before the first IS to improve adherence and reduce overall disease burden.
Degree
thesis:*- Name thesis:degree_name
- Master of Science - MSc
- Level thesis:degree_level
- master's
- Discipline thesis:degree_discipline
- Pharmaceutical Sciences
- Grantor dc:publisher
- University of British Columbia
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Shukkoor, Aashiq Ahamed
- Contributors dc:contributor
-
- Loewen, Peter
Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Language dc:language
- eng
Identifiers
dc:identifier.*- Handle dc:identifier
- http://hdl.handle.net/2429/92009